Free Trial
ASX:GSS

Genetic Signatures (GSS) Stock Price, News & Analysis

Genetic Signatures logo

About Genetic Signatures Stock (ASX:GSS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
A$120.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GSS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genetic Signatures and its competitors with MarketBeat's FREE daily newsletter.

GSS Stock News Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Bell Potter Sticks to Its Buy Rating for Genetic Signatures Ltd. (GSS)
Bell Potter Reaffirms Their Buy Rating on Genetic Signatures Ltd. (GSS)
See More Headlines

GSS Stock Analysis - Frequently Asked Questions

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
ASX:GSS
CIK
N/A
Fax
N/A
Employees
1,626
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$17.86 million
Net Margins
-182.90%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$13.77 million
Price / Cash Flow
N/A
Book Value
A$0.29 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$120.38 million
Optionable
Not Optionable
Beta
0.05
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (ASX:GSS) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners